InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by Gupta Suneel, Directeur. Director active across 1 companies, notably Protagonist Therapeutics, Inc. Aggregated, 4 filings have been recorded. The latest transaction was disclosed on 26 April 2022 — Levée d'options. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€277,34940,000 shares@ €6.93370.0051% mcap95.2% of flow
Common Stock
SEC:0001104659-22-050560:0·
€14,093649 shares@ €21.71530.0003% mcap4.8% of flow
Common Stock
SEC:0001104659-22-029522:0·
012,500 shares0
Common Stock
SEC:0001104659-22-024838:0·
012,500 shares0
Common Stock
SEC:0001104659-22-024838·
4 of 4 declarations
About Gupta Suneel
Suneel Gupta serves as the Chief Development Officer at Protagonist Therapeutics, Inc. In this role, he is responsible for leading strategic development and innovation initiatives within the company. His expertise in the biotechnology field contributes to the advancement of research and development projects.
